Cargando…
Safety, efficacy and patient acceptability of the combined estrogen and progestin transdermal contraceptive patch: a review
The worldwide introduction of the first, unique patch for hormonal contraception (ethinyl estradiol/norelgestromin, EE/NGMN patch) was widely recognized as a significant event in the development of drug delivery systems. This innovation offers a number of advantages over the oral route, and extensiv...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770395/ https://www.ncbi.nlm.nih.gov/pubmed/19920983 |
_version_ | 1782173649404428288 |
---|---|
author | Graziottin, Alessandra |
author_facet | Graziottin, Alessandra |
author_sort | Graziottin, Alessandra |
collection | PubMed |
description | The worldwide introduction of the first, unique patch for hormonal contraception (ethinyl estradiol/norelgestromin, EE/NGMN patch) was widely recognized as a significant event in the development of drug delivery systems. This innovation offers a number of advantages over the oral route, and extensive clinical trials have proved its safety, efficacy, effectiveness, and tolerability. The weekly administration and ease of use/simplicity of the EE/NGMN patch contribute to its acceptability, and help to resolve the two main problems of non-adherence, namely early discontinuation and inconsistent use. The patch offers additional benefits to adolescents (improvement of dysmenorrhea and acne), adults (improvement in emotional and physical well-being, premenstrual syndrome, and menstrual irregularities), and perimenopausal women (correction of hormonal imbalance, modulation of premenopausal symptoms), thus providing high satisfaction rates (in nearly 90% of users). Since its introduction, the transdermal contraceptive patch has proved to be a useful choice for women who seek a convenient formulation which is easy to use, with additional, non-contraceptive tailored benefits for all the ages. |
format | Text |
id | pubmed-2770395 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-27703952009-11-17 Safety, efficacy and patient acceptability of the combined estrogen and progestin transdermal contraceptive patch: a review Graziottin, Alessandra Patient Prefer Adherence Review The worldwide introduction of the first, unique patch for hormonal contraception (ethinyl estradiol/norelgestromin, EE/NGMN patch) was widely recognized as a significant event in the development of drug delivery systems. This innovation offers a number of advantages over the oral route, and extensive clinical trials have proved its safety, efficacy, effectiveness, and tolerability. The weekly administration and ease of use/simplicity of the EE/NGMN patch contribute to its acceptability, and help to resolve the two main problems of non-adherence, namely early discontinuation and inconsistent use. The patch offers additional benefits to adolescents (improvement of dysmenorrhea and acne), adults (improvement in emotional and physical well-being, premenstrual syndrome, and menstrual irregularities), and perimenopausal women (correction of hormonal imbalance, modulation of premenopausal symptoms), thus providing high satisfaction rates (in nearly 90% of users). Since its introduction, the transdermal contraceptive patch has proved to be a useful choice for women who seek a convenient formulation which is easy to use, with additional, non-contraceptive tailored benefits for all the ages. Dove Medical Press 2008-02-02 /pmc/articles/PMC2770395/ /pubmed/19920983 Text en © 2008 Dove Medical Press Limited. All rights reserved |
spellingShingle | Review Graziottin, Alessandra Safety, efficacy and patient acceptability of the combined estrogen and progestin transdermal contraceptive patch: a review |
title | Safety, efficacy and patient acceptability of the combined estrogen and progestin transdermal contraceptive patch: a review |
title_full | Safety, efficacy and patient acceptability of the combined estrogen and progestin transdermal contraceptive patch: a review |
title_fullStr | Safety, efficacy and patient acceptability of the combined estrogen and progestin transdermal contraceptive patch: a review |
title_full_unstemmed | Safety, efficacy and patient acceptability of the combined estrogen and progestin transdermal contraceptive patch: a review |
title_short | Safety, efficacy and patient acceptability of the combined estrogen and progestin transdermal contraceptive patch: a review |
title_sort | safety, efficacy and patient acceptability of the combined estrogen and progestin transdermal contraceptive patch: a review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770395/ https://www.ncbi.nlm.nih.gov/pubmed/19920983 |
work_keys_str_mv | AT graziottinalessandra safetyefficacyandpatientacceptabilityofthecombinedestrogenandprogestintransdermalcontraceptivepatchareview |